KLOW Blend Peptide Pharmacokinetics & Metabolism Absorption & Distribution KLOW Blend pharmacokinetics reflect the combined properties of four component peptides, each with distinct absorption and distribution characteristics[19]
Several investigators have shown that orally administered GSH increases plasma concentrations of reduced and protein-bound GSH through intestinal absorption in animal models 10,13,15 and humans
In patients with retinal vein occlusion, elevated serum oxidative stress marker levels, such as MDA, 8OHdG or H 2 O 2 were detected, while scavenging enzymes for ROS, such as SOD, were decreased [317]
Due to the lack of human trials, BPC-157 is not FDA-approved, and it cant be legally sold as a dietary supplement or possessed for human use